Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
WuXi AppTec (药明康德) received a 2009 Lilly Global...
ChinaBio® Today profiled Sinoasis Pharmaceuticals,...
WuXi PharmaTech (药明康德) announced a 5% increase in...
WuXi PharmaTech (药明康德) reported a 5%...
As China biopharma continues to evolve, the once dominant...
WuXi PharmaTech (药明康德) was named one of the Top...
As the feeling of economic crisis recedes, other –...
WuXi PharmaTech (药明康德), the Shanghai CRO,...
Cheezheng Tibetan Medicine was approved to IPO on the...
WuXi PharmaTech (药明康德) has signed a letter of...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
